Pentec Health provides patient-specific compounded sterile medications for administration in dialysis centers, as well as provides of in-home specialty infusion services and complex pharmaceutical products to patients who require access outside of a hospital setting.

NEP sold Pentec Health to Wellspring Capital in October 2021.